Johns Hopkins scientists develop nose spray DNA vaccine for tuberculosis

Summary

Johns Hopkins scientists developed an intranasal DNA vaccine for tuberculosis that showed promising results in animal studies, including faster infection clearance, reduced lung inflammation, and enhanced efficacy with existing TB drugs.